🚨 Big News! 🚨
We’re thrilled to share that our portfolio company, Little Journey, has secured a £6M Series A round led by Par Equity, joined by us, Octopus Ventures, Mercia Ventures and British Business Bank North of England.
This funding is a major step forward in Little Journey’s mission to revolutionise paediatric care with personalised psychological support for young patients and their families. By empowering children and families to approach medical procedures with confidence and ease, Little Journey is making a lasting impact on paediatric healthcare. 💙✨
Congratulations to Chris Evans, Sophie Copley, and the entire Little Journey team on reaching this incredible milestone! The future of paediatric healthcare has never looked brighter, and we’re excited to support what’s next.
For more details on Little Journey’s next steps, check out the full press release in the comments. 📖
#SeriesA#HealthTech#PaediatricCare#Innovation#Impact#Growth
Impact isn’t just about returns; it’s about relationships.
The true value of investing lies beyond the numbers—it’s in the connections you build and the impact you create. Jay Zeidman’s journey from the White House to venture capital embodies this ethos.
- Making meaningful investments in healthcare isn’t charity; it’s about value-add.
- Real experience in startups shapes better investment decisions.
- Houston is more than a city; it’s a community worth investing in.
Let’s redefine what it means to invest. How do you view the role of relationships in business?
https://lnkd.in/d3z2fe72#ImpactInvesting#Healthcare#VentureCapital#Houston
This is an unconventional way to raise money but when have I ever been conventional?
SOAP Health has 45 people on its team of which 41 work on our applications. We have no formal sales or marketing people, except for me, and I am not a salesperson (ask anyone who knows me - I tend to overshare).
The good news is our application essentially sells itself with 50+ practices (80+% closing rate) already under contract and multimillion dollar agreements signed with the NIH and NHS.
What's at stake?
SOAP has built the World's First AI Doctor, capable of doing virtually everything a doctor does except for the physical exam and an occasional kind embrace. It is meant to bolster existing health professionals' workflows and eliminate misdiagnosis.
SOAP is currently funded solely by me after net raising five million. An incredible amount was accomplished already for that money including an issued patent and another pending. Some money is still due from the NIH and NHS.
SOAP is looking for additional capital to accelerate customer implementations, product development, and market expansion.
Right now, investors can get in at the last valuation offered two years ago and the price at which I keep investing. Black Friday is coming early this year for digital health investors. (The truth is I'd love all SOAP investors current and future to do very well.)
The ASK:
Accredited Investors that want to do well by doing good and are willing to invest up to $2M ($50K minimum). I will personally invest an additional matching $1M.
If you're interested, let's speak. If not, think again. Rare opportunities to help fix medicine and do well by doing good don't come along everyday...
#raisingmoney#seedextension#accreditedinvestor#fixingmedicine#swinngforthefences#dontinvestwhatyoucantaffordtolose#equity#angels#angelinvestor#angel
It’s incredibly humbling to be part of such a significant category for care transformation, on a national scale. As our CMO Sameer Berry says, “In GI, it’s the patient that drives the utilization of care” – which shows up when they’re not feeling well and can’t get in to see a specialist, they turn to the emergency room. This is why GI symptoms are the #1 cause of avoidable ER visits.
Without access to high-touch multidisciplinary care, it can take years to get to a diagnosis and the root cause of GI issues. Along the way patients are racking up costs and often spinning in circles.
When patients have access to Oshi care – as much care as they need to feel better and ideally with no out of pocket costs and fixed costs for the employer/plan – they get to the answers they seek. They are empowered through longer visits, frequent touchpoints, conservative interventions (that patients appreciate) and true medical care that uses all of the evidence-based clinical levers to get them feeling better, faster, and able to keep their symptoms under control.
It takes a powerful coalition of clinicians, leaders, partners and investors to truly make a difference in our healthcare system. There’s something special happening here.
Thank you to Oak HC/FT and all of our amazing investors: Bessemer Venture Partners, Frist Cressey Ventures, Takeda Digital Ventures, Koch Disruptive Technologies, Flare Capital Partners and CVS Health Ventures for your continued commitment and support of this important mission.
And none of this is possible without innovative employers and health plans partnering with us to ensure that this care is accessible and top of mind for their members.
A wise friend often says “better is possible”, and this funding increases the likelyhood that millions of people with digestive diseases can realize that fact.
🚀 Big news! Oshi Health has raised $60 million in Series C funding, led by Oak HC/FT, to fuel our mission of transforming digestive health care! 🌱
"Digestive health is an urgent and under-resourced category, and Oshi stands out for its proven clinical care that delivers faster relief for patients and significant savings for employers," said Nancy G. Brown, General Partner at Oak HC/FT.
With participation from existing investors Bessemer Venture Partners, Flare Capital Partners, Frist Cressey Ventures, CVS Health Ventures, and Takeda Digital Ventures, this funding will help us accelerate our partnerships with provider groups, expand payer coverage, service new employer partners, and expand to serve Medicare populations in 2025.
Together, we’re tackling one of Americans’ most pervasive set of conditions, delivering faster relief for millions and bending the curve on population health costs.
A huge thank you to all our investors for supporting our vision. 🙌
Let’s reshape digestive health care—one patient at a time.
Read our announcement: https://lnkd.in/ekhujU_B#SeriesC#DigestiveHealth#VirtualCare#HealthcareInnovation#OshiHealth
Elder and Disabled Care Capital Raises in the U.S. - October 1st-15th, 2024
Some interesting transactions closed in the Elder and Disabled Care sector this week. If you would like more info on these deals or would like to discuss the capital raising market for your company, please contact me.
Merger/Acquisition and Corporate
1. Claremont Hacienda, operator of a memory care community catering to individuals with memory impairment, was acquired by Generations Healthcare.
2. Longevity Health Plan and Infinity Healthcare Consulting, clinical care and therapy services intended for senior citizens, formed as a joint venture.
3. Scenic Mountain Medical Center, provider of healthcare and emergency services based in Big Spring, Texas, a subsidiary of Steward Health Care, was acquired by Quorum Health.
4. Console Hospice, provider of care services intended to serve the San Fernando Valley and Greater Los Angeles Area, was acquired.
Early Stage VC
5. Rippl Care, operator of a mental health company intended to overcome neurocognitive conditions like Alzheimer's disease and other dementias, raised $23 million of Series A venture funding in a deal led by Kin Ventures, putting the company's pre-money valuation at $85 million.
#castleplacement#capitalraising#privateequity#venturecapital#investment#ElderCare#DisabledCare
Calling all Founders!! 📣
In the evolving digital health industry, there is no one-size-fits-all approach for success. However, tapping into the collective insights of peers who are also navigating their entrepreneurial journeys can provide practical guidance and fresh perspectives, especially for newcomers dealing with the complexities of the healthcare market.
This roundtable is designed to facilitate a rich exchange of ideas and collaborative problem-solving, focusing on real-world experiences. Engage with fellow founders to explore both the common and unique challenges within the digital health landscape.
Join us to discuss how to navigate these complex times and learn best practices from each other including:
1) alternative funding approaches in this difficult market
2) how to partner effectively with every changing stakeholders
3) how to scale and hire for sucess
Looking forward to seeing you there!
https://lnkd.in/dQX74rQhHLTH Inc.Chandana Fitzgeraldnen
Navigating the complex world of digital health?
Join our Startup Founder Connect roundtable discussion featuring Francesca Wuttke (nen) and Chandana Fitzgerald (HLTH Community)
🔥 Hot topics on the agenda:
✅ Cracking the fundraising code
✅ Scaling secrets unveiled
✅ Partnership strategies that work
Register Now ➡️ https://lnkd.in/eSJQZkBc
This isn't group therapy - it's your launchpad to success! 🚀
Limited spots available. Are you in?
#HealthTechInnovators#StartupGrowth#HLTH
In 21 states, at least 50% of all methadone clinics are owned either by private equity firms or by Acadia Healthcare, a publicly traded company founded by private equity firm Waud Capital Partners.
100% of all clinics in Louisiana, Nebraska, New Hampshire, and Montana are owned either by Acadia or by private equity firms.
The shift toward private-equity-backed treatment in the U.S. has raised questions about what methadone clinics’ real interests are in the public policy debate. While there's no evidence that for-profit clinics offer lower-quality care, experts say private equity firms are investing with the expectation that methadone clinics will increase in value. Where does that leave people in recovery?
Part 3 of The War on Recovery examines the methadone clinic monopoly. Read: https://trib.al/Wr0Zwz8
If you read nothing else today, read this excellent case for new, bold policies on primary care.
To wit: 'Private equity and corporate investment does not work: Corporate and private equity investors—seeking extractive short-term financial returns and not committed to long-term investment—destabilize an already fragile primary care sector......The failing experiment of corporate, investor-owned primary care highlights the need for bold public policy to address primary care payment, infrastructure, and corporate ownership.'
As always thanks to MHQP for bringing attention to an impending healthcare crisis.
President and CEO at Massachusetts Health Quality Partners
Thank you Kevin Grumbach, Deborah Cohen and Yalda Jabbarpour for your important article on the failing experiment of primary care as a for profit enterprise. Unfortunately in Massachusetts we are heading right into the dragon’s den with the announced acquisition of Steward physician network by private equity firm Kinderhook. https://lnkd.in/e9-bBRxs
https://www.littlejourney.health/news/little-journey-raises-6m-series-a